Sun Pharmaceutical Industries Ltd Q3FY23 consolidated profit at Rs. 2166.01 crores

The Board of Directors of Sun Pharmaceutical Industries Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.

Related Keywords

,Sun Pharmaceutical Industries ,Sun Pharmaceutical Industries Ltd ,Pharmaceutical Industries Limited ,Sun Pharmaceutical Industries Limited ,Sunpharmaceuticalindustries ,Q3fy23 ,9mfy23 ,Resultupdate ,